Vishwas Seshadri, Chief Executive Officer at Abeona Therapeutics (NASDAQ:ABEO), reported a large insider buy on September 29, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Friday showed that Seshadri purchased 20,000 shares of Abeona Therapeutics. The total transaction amounted to $81,400.
Abeona Therapeutics shares are trading up 0.76% at $3.96 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to make an investing decision, however ...